{Reference Type}: Journal Article
{Title}: The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients.
{Author}: Cecerska-Heryć E;Polikowska A;Serwin N;Michalczyk A;Stodolak P;Goszka M;Zoń M;Budkowska M;Tyburski E;Podwalski P;Waszczuk K;Rudkowski K;Kucharska-Mazur J;Mak M;Samochowiec A;Misiak B;Sagan L;Samochowiec J;Dołęgowska B;
{Journal}: Schizophr Res
{Volume}: 270
{Issue}: 0
{Year}: 2024 Aug 7
{Factor}: 4.662
{DOI}: 10.1016/j.schres.2024.05.018
{Abstract}: <B>BACKGROUND: </B>The etiology of schizophrenia (SCZ), an incredibly complex disorder, remains multifaceted. Literature suggests the involvement of oxidative stress (OS) in the pathophysiology of SCZ.<BR><B>OBJECTIVE: </B>Determination of selected OS markers and brain-derived neurotrophic factor (BDNF) in patients with chronic SCZ and those in states predisposing to SCZ-first episode psychosis (FP) and ultra-high risk (UHR).<BR><B>METHODS: </B>Determination of OS markers and BDNF levels by spectrophotometric methods and ELISA in 150 individuals (116 patients diagnosed with SCZ or in a predisposed state, divided into four subgroups according to the type of disorder: deficit schizophrenia, non-deficit schizophrenia, FP, UHR). The control group included 34 healthy volunteers.<BR><B>RESULTS: </B>Lower activities of analyzed antioxidant enzymes and GSH and TAC concentrations were found in all individuals in the study group compared to controls (p < 0.001). BDNF concentration was also lower in all groups compared to controls except in the UHR subgroup (p = 0.01). Correlations were observed between BDNF, R-GSSG, GST, GPx activity, and disease duration (p < 0.02). A small effect of smoking on selected OS markers was also noted (rho<0.06, p < 0.03).<BR><B>CONCLUSIONS: </B>OS may play an important role in the pathophysiology of SCZ before developing the complete clinical pattern of the disorder. The redox imbalance manifests itself with such severity in individuals with SCZ and in a state predisposing to the development of this psychiatric disease that natural antioxidant systems become insufficient to compensate against it completely. The discussed OS biomarkers may support the SCZ diagnosis and predict its progression.